In Vivo Reactive Oxygen Species Detection With a Novel Positron Emission Tomography Tracer, 18F-DHMT, Allows for Early Detection of Anthracycline-Induced Cardiotoxicity in Rodents-Reference-Cited by-同舟云学术

In Vivo Reactive Oxygen Species Detection With a Novel Positron Emission Tomography Tracer, 18F-DHMT, Allows for Early Detection of Anthracycline-Induced Cardiotoxicity in Rodents

Published:2018-06 Issue:3 Volume:3 Page:378-390
ISSN:2452-302X
Container-title:JACC: Basic to Translational Science
language:en
Short-container-title:JACC: Basic to Translational Science

Author:

Boutagy Nabil E.,Wu Jing,Cai Zhengxi,Zhang Wenjie,Booth Carmen J.,Kyriakides Tassos C.,Pfau Daniel,Mulnix Tim,Liu Zhao,Miller Edward J.,Young Lawrence H.,Carson Richard E.,Huang Yiyun,Liu Chi,Sinusas Albert J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference50 articles.

1. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management;Yeh;J Am Coll Cardiol,2009

2. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials;Swain;Cancer,2003

3. Risk factors for doxorubicin-induced congestive heart failure;Von Hoff;Ann Intern Med,1979

4. The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy;Russell;J Nucl Cardiol,2016

5. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving adriamycin;Ewer;J Clin Oncol,1984

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lubricating adhesive hyaluronate patch promotes cartilage regeneration and functional restoration in osteoarthritis;Applied Materials Today;2024-08

2. Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity;Frontiers in Cardiovascular Medicine;2024-05-16

3. Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives;Journal of Nuclear Medicine;2023-11

4. Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine;Current Issues in Molecular Biology;2023-10-15

5. Promising Radiopharmaceutical Tracers for Detection of Cardiotoxicity in Cardio-oncology;Current Radiopharmaceuticals;2023-09